MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3145.20%
Quick Ratio
3145.20%
Cash Ratio
743.29%
Debt to Asset Ratio
2.74%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
44,107
8,356
35,685
25,803
Short-term marketable securities
139,016
101,208
65,395
61,098
Prepaid expenses and other current assets
3,513
3,840
4,769
4,063
Total current assets
186,636
113,404
105,849
90,964
Long-term marketable securities
56,098
36,741
59,572
88,930
Operating lease right-of-use assets
1,216
447
505
562
Property and equipment, net
695
250
288
318
Other long-term assets
1,649
1,530
1,530
1,530
Total assets
246,294
152,372
167,744
182,304
Accounts payable
1,133
860
2,269
477
Accrued expenses and other current liabilities
4,300
2,948
4,459
4,244
Operating lease liabilities
501
263
256
228
Total current liabilities
5,934
4,071
6,984
4,949
Operating lease liabilities, net of current portion
813
216
285
352
Total liabilities
6,747
4,287
7,269
5,301
Common stock, 0.0001 par value 250,000,000 shares authorized 57,436,255 and 47,766,338 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
5
5
7
Additional paid-in capital
556,555
451,372
449,762
448,738
Accumulated other comprehensive income (loss)
-67
157
435
469
Accumulated deficit
-316,947
-303,449
-289,727
-272,211
Total stockholders' equity (deficit)
239,547
148,085
160,475
177,003
Total liabilities and stockholders' equity (deficit)
246,294
152,372
167,744
182,304
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$139,016K (124.14%↑ Y/Y)Cash and cashequivalents$44,107K (94.46%↑ Y/Y)Prepaid expenses andother current assets$3,513K (31.03%↑ Y/Y)Total current assets$186,636K (113.58%↑ Y/Y)Long-term marketablesecurities$56,098K (-45.38%↓ Y/Y)Other long-termassets$1,649K (20.54%↑ Y/Y)Operating leaseright-of-use assets$1,216K (96.76%↑ Y/Y)Property and equipment,net$695K (121.34%↑ Y/Y)Total assets$246,294K (28.02%↑ Y/Y)Total liabilities andstockholders' equity...$246,294K (28.02%↑ Y/Y)Total stockholders'equity (deficit)$239,547K (28.95%↑ Y/Y)Total liabilities$6,747K (1.89%↑ Y/Y)Accumulated deficit-$316,947K (-22.22%↓ Y/Y)Accumulated othercomprehensive income (loss)-$67K (-121.07%↓ Y/Y)Additional paid-in capital$556,555K (25.14%↑ Y/Y)Total currentliabilities$5,934K (-4.37%↓ Y/Y)Operating leaseliabilities, net of current...$813K (94.96%↑ Y/Y)Common stock, 0.0001par value...$6K (-14.29%↓ Y/Y)Accrued expenses andother current...$4,300K (-14.63%↓ Y/Y)Accounts payable$1,133K (19.77%↑ Y/Y)Operating leaseliabilities$501K (125.68%↑ Y/Y)

Climb Bio, Inc. (CLYM)

Climb Bio, Inc. (CLYM)